Oragenics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
16,276.50
10,448.90
5,083.40
4,080.60
6,166.10
20,208.30
Total Accounts Receivable
64.40
15.60
-
-
-
-
Inventories
288.40
439.20
-
-
-
-
Other Current Assets
175.20
119.40
554.40
141.10
1,027.00
1,725
Total Current Assets
16,804.60
11,023.10
5,637.70
4,221.70
7,193.20
21,933.30
Net Property, Plant & Equipment
26.90
109.30
140.70
87.50
21.70
116.30
Long-Term Note Receivable
-
-
-
30.60
-
-
Total Assets
16,831.50
11,132.40
5,778.40
4,339.70
7,214.80
22,049.60
ST Debt & Current Portion LT Debt
64.10
64.80
63.40
66.40
80.50
Accounts Payable
249.20
483.60
831.00
1,277.10
618.40
Other Current Liabilities
679.60
247.80
153.00
0.00
199.70
Total Current Liabilities
992.80
796.30
1,047.40
1,343.40
898.50
Total Liabilities
992.80
796.30
1,047.40
1,343.40
898.50
Common Equity (Total)
15,838.60
10,336.10
4,731.00
2,996.30
6.70
Total Shareholders' Equity
15,838.60
10,336.10
4,731.00
2,996.30
6,316.30
Total Equity
15,838.60
10,336.10
4,731.00
2,996.30
6,316.30
Liabilities & Shareholders' Equity
16,831.50
11,132.40
5,778.40
4,339.70
7,214.80
Preferred Stock (Carrying Value)
-
-
-
-
6,309.60
About Oragenics
View Profile
